Foodborne enterotoxigenic Escherichia coli: From gut pathogenesis to new preventive strategies involving probiotics

Future Microbiology

Volumn 12, Issue 1, 2017, Pages 73-93

  Roussel, Charlène ^a,b   Sivignon, Adeline ^a   De Wiele, Tom Van ^b   Blanquet Diot, Stéphanie ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

ETEC; foodborne pathogen; gastrointestinal cues; in vitro digestion models; nutritional strategies; pig; probiotics; ST LT toxins; vaccine; virulence factors

Indexed keywords

CATECHOLAMINE; PROBIOTIC AGENT; TRACE ELEMENT;

ALTERNATIVE MEDICINE; ANTIBIOTIC THERAPY; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; DIARRHEA; DIGESTION; ENTERITIS; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI INFECTION; GASTROINTESTINAL TRACT; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE FLORA; NONHUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; REVIEW; VACCINATION; ESCHERICHIA COLI INFECTIONS; FOODBORNE DISEASES; GASTROINTESTINAL DISEASES; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FOODBORNE DISEASES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN-ION CONCENTRATION; PROBIOTICS;

EID: 85006993578     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb-2016-0101     Document Type: Review

References (102)

1. Clements A, Young JC, Constantinou N, Frankel G. Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes 3(2), 71-87 (2012).
2. Qadri F, Svennerholm AM, Faruque ASG, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 18(3), 465-483 (2005).
3. Kotloff KL, Nataro JP, Blackwelder WC et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382(9888), 209-222 (2013a).
4. Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N. Vaccination against enterotoxigenic Escherichia coli, a cause of traveler's diarrhea. J. Travel. Med. 12(2), 102-107 (2005).
5. Lanata CF, Fischer-Walker CL, Olascoaga AC et al. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS ONE 8(9), e72788 (2013).
6. CDC (2014). http://www.cdc.gov/ecoli/etec.html
7. Doyle MP, Padhye VV. Escherichia coli. In: Foodborne Bacterial Pathogens. Doyle MP (Ed.). Marcel Dekker, NY, USA, 235-281 (1989).
8. Lothigius A, Sjöling A, Svennerholm AM, Bölin I. Survival and gene expression of enterotoxigenic Escherichia coli during long-term incubation in sea water and freshwater. J. Appl. Microbiol. 108(4), 1441-1449 (2010).
9. Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB, Young CR. Immunity to enterotoxigenic Escherichia coli. Infect. Immun. 23(3), 729-736 (1979).
10. Harris AM, Chowdhury F, Begum YA et al. Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during foods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am. J. Trop. Med. Hyg. 79(5), 708-714 (2008).
11. Yoder JS, Cesario S, Plotkin V, Ma X, Kelly-Shannon K, Dworkin MS. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin. Infect. Dis. 42(11), 1513-1517 (2006).
12. Torres OR, González W, Lemus O et al. Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala. Epidemiol. Infect. 143(8), 1662-1671 (2015).
13. Stintzing G, Möllby R. Colonization of the upper jejunum by enteropathogenic and enterotoxigenic Escherichia coli in paediatric diarrhoea. Acta. Paediatr. Scand. 71(3), 457-465 (1982).
14. Allen KP, Randolph MM, Fleckenstein JM. Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains. Infect. Immun. 74(2), 869-875 (2006).
15. Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 12(2), 89-98 (2010).
16. Luo Q, Kumar P, Vickers TJ et al. Enterotoxigenic Escherichia coli secretes a highly conserved mucin-degrading metalloprotease to effectively engage intestinal epithelial cells. Infect. Immun. 82(2), 509-521 (2014).
17. Kumar P, Luo Q, Vickers TJ, Sheikh A, Lewis WG, Fleckenstein JM. EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin. Infect. Immun. 82(2), 500-508 (2014).
18. Dubreuil JD. The whole shebang: the gastrointestinal tract, Escherichia coli enterotoxins and secretion. Curr. Issues Mo l. Biol. 14(2), 71-82 (2012).
19. Read LT, Hahn RW, Thompson CC, Bauer DL, Norton EB, Clements JD. Simultaneous exposure to Escherichia coli heat-labile and heat-stable enterotoxins increases fuid secretion and alters cyclic nucleotide and cytokine production by intestinal epithelial cells. Infect. Immun. 82(12), 5308-5316 (2014).
20. Johnson AM, Kaushik RS, Rotella NJ, Hardwidge PR. Enterotoxigenic Escherichia coli modulates host intestinal cell membrane asymmetry and metabolic activity. Infect. Immun. 77(1), 341-347 (2009).
21. Mercado EH, Ochoa TJ, Ecker L et al. Fecal leukocytes in children infected with diarrheagenic Escherichia coli. J. Clin. Microbiol. 49(4), 1376-1381 (2011).
22. Yu Q, Yuan L, Deng J, Yang Q. Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria. Front. Cell Infect. Microbiol. 5, 26 (2015).
23. Villena J, Kitazawa H. Modulation of intestinal TLR4-infammatory signaling pathway by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937 Front. Immunol. 4(512), 1-12 (2013).
24. Wang X, Hardwidge PR. Enterotoxigenic Escherichia coli prevents host NF-KB activation by targeting IKBCC polyubiquitination. Infect. Immun. 80(12), 4417-4425 (2012).
25. Wang X, Gao X, Hardwidge PR. Heat-labile enterotoxin-induced activation of NF-KB and MAPK pathways in intestinal epithelial cells impacts enterotoxigenic Escherichia coli (ETEC) adherence. Cell. Microbiol. 14(8), 1231-1241 (2012).
26. Gonzales-Siles L, Sjöling Å. The different ecological niches of enterotoxigenic Escherichia coli. Environ. Microbiol. 18, 741-751 (2016).
27. Masters CI, Shallcross JA, Mackey BM. Effect of stress treatments on the detection of Listeria monocytogenes and enterotoxigenic Escherichia coli by the polymerase chain reaction. J. Appl. Bacteriol. 77(1), 73-79 (1994).
28. Gonzales L, Ali ZB, Nygren E et al. Alkaline pH Is a signal for optimal production and secretion of the heat labile toxin, LT in enterotoxigenic Escherichia coli (ETEC). PLoS ONE 8(9), e74069 (2013).
29. Johnson WM, Lior H, Johnson KG. Heat-stable enterotoxin from Escherichia coli: factors involved in growth and toxin production. Infect. Immun. 20(2), 352-359 (1978).
30. Chatterjee A, Chowdhury R. Bile and unsaturated fatty acids inhibit the binding of cholera toxin and Escherichia coli heat-labile enterotoxin to GM1 receptor. Antimicrob. Agents Chemother. 52(1), 220-224 (2008).
31. Nicklasson M, Sjöling Å, Von Mentzer A, Qadri F, Svennerholm AM. Expression of colonization factor CS5 of enterotoxigenic Escherichia coli (ETEC) is enhanced in vivo and by the bile component Na glycocholate hydrate. PLoS ONE 7(4), e35827 (2012).
32. Sahl JW, Rasko DA. Analysis of global transcriptional profles of enterotoxigenic Escherichia coli isolate E24377A. Infect. Immun. 80(3), 1232-1242 (2012).
33. Kunkel SL, Robertson DC. Factors affecting release of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Infect. Immun. 23(3), 652-659 (1979).
34. Rappaport RS, Sagin JF, Pierzchala WA, Bonde G, Rubin BA, Tint H. Activation of Heat-labile Escherichia coli enterotoxin by trypsin. J. Infect. Dis. 133 Suppl, 41-54 (1976).
35. Wijemanne P, Moxley RA. Glucose signifcantly enhances enterotoxigenic Escherichia coli adherence to intestinal epithelial cells through its effects on heat-labile enterotoxin production. PLoS ONE 9 (11), e113230 (2014).
36. Bodero MD, Munson GP. Cyclic AMP receptor protein-dependent repression of heat-labile enterotoxin. Infect. Immun. 77(2), 791-798 (2009).
37. Haines S, Gautheron S, Nasser W, Renauld-Mongénie G. Identifcation of novel components infuencing colonization factor antigen I expression in enterotoxigenic Escherichia coli. PLoS ONE 10 (10), e0141469 (2015).
38. David LA, Weil A, Ryan ET et al. Gut microbial succession follows acute secretory diarrhea in humans. MBio 6(3), e 00381-e 00315 (2015).
39. Takashi K, Fujita I, Kobari K. Effects of short chain fatty acids on the production of heat-labile enterotoxin from enterotoxigenic Escherichia coli. Japan. J. Pharmacol. 50(4), 495-498 (1989).
40. Freestone P. Communication between bacteria and their hosts. Scientifca 2013, 361073 (2013).
41. Lyte M, Erickson AK, Arulanandam BP, Frank CD, Crawford MA, Francis DH. Norepinephrine-induced expression of the K99 pilus adhesion of enterotoxigenic Escherichia coli. Biochem. Biophys. Res. Comm. 323, 682-686 (1997).
42. Sturbelle RT, da Costa de Avila LF, Roos TB et al. The role of quorum sensing in Escherichia coli (ETEC) virulence factors. Vet. Microb. 180, 245-252 (2015).
43. Jelinek T, Kollaritsch H. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera. Expert Rev. Vaccines 7(5), 561-567 (2008).
44. Nickonchuk T, Lindblad AJ, Kolber MR. Oral cholera vaccine for traveler's diarrhea prophylaxis. Can. Fam. Physician 60(5), 451 (2014).
45. Zhang W, Sack DA. Current progress in developing subunit vaccines against enterotoxigenic Escherichia coli-associated diarrhea. Clin. Vaccine Immunol. 22(9), 983-991 (2015).
46. Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst. Rev. 7, CD009029 (2013).
47. Galvao TF, Thees S, Pontes RF, Silva MT, Pereira MG. Zinc supplementation for treating diarrhea in children: a systematic review and meta-analysis. Rev. Panamericana de Salud Pública 33(5), 370-377 (2013).
48. Sheikh A, Shamsuzzaman S, Ahmad SM et al. Zinc infuences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea. J. Nutr. 140 (5), 1049-1056 (2010).
49. Roselli M, Finamore A, Garaguso I, Britti MS, Mengheri E. Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli. J. Nutr. 133(12), 4077-4082 (2003).
50. Karjalainen TK, Evans DG, Evans DJ, Graham DY, and Lee CH. Iron represses the expression of CFA/I fmbriae of enterotoxigenic E. coli. Microb. Pathog. 11(5), 317-323 (1991).
51. Salem W, Leitner DR, Zingl FG et al. Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli. Int. J. Med. Microbiol. 305(1), 85-95 (2015).
52. Verhelst R, Schroyen M, Buys N, Niewold TA. E. coli heat labile toxin (LT) inactivation by specifc polyphenols is aggregation dependent. Vet. Microbiol. 163(3-4), 319-324 (2013).
53. Bruins MJ, Vente-Spreeuwenberg MAM, Smits CH, Frenken LGJ. Black tea reduces diarrhoea prevalence but decreases growth performance in enterotoxigenic Escherichia coli-infected post-weaning piglets. J. Anim. Physiol. Anim. Nutr. (Berl.) 95(3), 388-398 (2011).
54. Verhelst R, Schroyen M, Buys N, Niewold T. Dietary polyphenols reduce diarrhea in enterotoxigenic Escherichia coli (ETEC) infected post-weaning piglets. Livest. Sci. 160, 138-140 (2014).
55. Long KZ, Santos JI, Rosado JL et al. Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. J. Infect. Dis. 194(9), 1217-1225 (2006).
56. Hill C, Guarner F, Reid G et al. Expert consensus document. The international scientifc association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11(8), 506-514 (2014).
57. Chapman CMC, Gibson GR, Rowland I. Health benefts of probiotics: are mixtures more effective than single strains? Eur. J. Nutr. 50, 1-17 (2011).
58. Timmerman HM, Koning CJM, Mulder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics-a comparison of functionality and effcacy. Int. J. of Food. Microbiol. 96, 219-233 (2004).
59. Preidis GA, Hill C, Guerrant RL, Ramakrishna BS, Tannock GW, Versalovic J. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 140(1), 8-14 (2011).
60. Murata K, Tomosada Y, Villena J et al. Bifdobacterium breve MCC-117 induces tolerance in porcine intestinal epithelial cells: study of the mechanisms involved in the immunoregulatory effect. Biosci. Microbiota Food Health 33(1), 1-10 (2014).
61. Zhou M, Zhu J, Yu H et al. Investigation into in vitro and in vivo models using intestinal epithelial IPEC-J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli. J. Appl. Microbiol. 117(1), 217-226 (2014).
62. Wachi S, Kanmani P, Tomosada Y et al. Lactobacillus delbrueckii TUA4408L and its extracellular polysaccharides attenuate enterotoxigenic Escherichia coli-induced infammatory response in porcine intestinal epitheliocytes via Toll-like receptor-2 and 4. Mol. Nutr. Food Res. 58(10), 2080-2093 (2014).
63. Tomosada Y, Villena J, Murata K et al. Immunoregulatory effect of bifdobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS ONE 8(3), e59259 (2013).
64. Badia R, Zanello G, Chevaleyre C et al. Effect of Saccharomyces cerevisiae var. Boulardii and β-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88). Vet. Res. 43, 4 (2012).
65. Zanello G, Berri M, Dupont J et al. Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS ONE 6(4), e18573 (2011a).
66. Roselli M, Finamore A, Britti MS et al. The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J. Nutr. 137(12), 2709-2716 (2007).
67. Klingspor S, Bondzio A, Martens H et al. Enterococcus faecium NCIMB 10415 modulates epithelial integrity, heat shock protein, and proinfammatory cytokine response in intestinal cells. Mediators Infamm. 304149 (2015).
68. Finamore A, Roselli M, Imbinto A, Seeboth J, Oswald IP, Mengheri E. Lactobacillus amylovorus inhibits the TLR4 infammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explants. PLoS ONE 9(4), e94891 (2014).
69. Khafpour E, Munyaka PM, Nyachoti CM, Krause DO, Rodriguez-Lecompte JC. Effect of crowding stress and Escherichia coli K88+ challenge in nursery pigs supplemented with anti-Escherichia coli K88+ probiotics. J. Anim. Sci. 92(5), 2017-2029 (2014).
70. Zhu YH, Li XQ, Zhang W, Zhou D, Liu HY, Wang JF. Dose-dependent effects of Lactobacillus rhamnosus on serum interleukin-17 production and intestinal T-cell responses in pigs challenged with Escherichia coli. Appl. Environ. Microbiol. 80(5), 1787-1798 (2014).
71. TM LP96 in gnotobiotic pigs challenged with enterotoxigenic Escherichia coli. Res. Vet. Sci. 95(1), 103-109 (2013).
72. Li XQ, Zhu YH, Zhang HF et al. Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances. PLoS ONE 7(7), e40666 (2012).
73. Zhang L, Xu YQ, Liu HY, Lai T, Ma JL, Wang JF, Zhu YH. Evaluation of Lactobacillus rhamnosus GG using an Escherichia coli K88 model of piglet diarrhoea: effects on diarrhoea incidence, faecal microfora and immune responses. Vet. Microbiol. 141(1-2), 142-148 (2010).
74. Tsai CC, Lin PP, Hsieh YM. Three Lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitro. Anaerobe 14(2), 61-67 (2008).
75. Hillman K, Spencer RJ, Murdoch TA, Stewart CS. The effect of mixtures of Lactobacillus spp. on the survival of enterotoxigenic Escherichia coli in in vitro continuous culture of porcine intestinal bacteria. Lett. Appl. Microbiol. 20(2), 130-133 (1995).
76. Trevisi P, Colombo M, Priori D et al. Comparison of three patterns of feed supplementations with live Saccharomyces cerevisiae yeast on postwean in diarrhea, health status, and blood metabolic profle of susceptible weaning pigs orally challenged with Escherichia coli F4ac. J. Anim. Sci. 93, 2225-2233 (2015).
77. Yang Y, Galle S, Le MH, Zijlstra RT, Ganzle MG. Feed fermentation with Reuteran-and-Levan-producing Lactobacillus reuteri reduces colonization of weanling pigs by enterotoxigenic Escherichia coli. Appl. Environ. Microbiol. 81(17), 5743-5752 (2015).
78. Lee JS, Awji EG, Lee SJ et al. Effect of Lactobacillus plantarum CJLP243 on the growth performance and cytokine response of weaning pigs challenged with enterotoxigenic Escherichia coli. J. Anim. Sci. 90(11), 3709-3717 (2012).
79. Konstantinov SR, Smidt H, Akkermans ADL et al. Feeding of Lactobacillus sobrius reduces Escherichia coli F4 levels in the gut and promotes growth of infected piglets. FEMS Microbiol. Ecol. 66(3), 599-607 (2008).
80. Wu Y, Zhu C, Chen Z et al. Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells. Vet. Immunol. Immunopathol. 172, 55-63 (2016).
81. Lodemann U, Strahlendorf J, Schierack P, Klingspor S, Aschenbach JR, Martens H. Effects of the probiotic Enterococcus faecium and pathogenic Escherichia coli strains in a pig and human epithelial intestinal cell model. Scientifca 2015, 235184 (2015).
82. Osmanagaoglu O, Kiran F, Ataoglu H. Evaluation of in vitro probiotic potential of Pediococcus pentosaceus OZF isolated from human breast milk. Probiotics Antimicrob. Proteins 2(3), 162-174 (2010).
83. Zhong SS, Zhang ZS, Wang JD et al. Competitive inhibition of adherence of enterotoxigenic Escherichia coli, enteropathogenic Escherichia coli and Clostridium diffcile to intestinal epithelial cell line Lovo by purifed adhesin of Bifdobacterium adolescentis 1027. World J. Gastroenterol. 10(11), 1630-1633 (2004).
84. Fujiwara S, Hashiba H, Hirota T, Forstner JF. Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifdobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surface. Int. J. Food Microbiol. 67(1-2), 97-106 (2001).
85. Trevisi P, Latorre R, Priori D et al. Effect of feed supplementation with live yeast on the intestinal transcriptompe profle of weaning pigs orally challenged with Escherichia coli F4. Animal, 30, 1-12 (2016).
86. Yang KM, Jiang ZY, Zheng CT, Wang L, Yang X F. Effect of Lactobacillus plantarum on diarrhea and intestinal barrier function of young piglets challenged with enterotoxigenic Escherichia coli K88. J. Anim. Sci. 92(4), 1496-1503 (2014).
87. Daudelin JF, Lessard M, Beaudoin F et al. Administration of probiotics infuences F4 (K88)-positive enterotoxigenic Escherichia coli attachment and intestinal cytokine expression in weaned pigs. Vet. Res. 42, 69 (2011).
88. Ouwehand AC, ten Bruggencate SJM, Schonewille AJ, Alhoniemi E, Forssten SD, Bovee-Oudenhoven IMJ. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection. Br. J. Nutr. 111(3), 465-473 (2014).
89. Ten Bruggencate SJM, Girard SA, Floris-Vollenbroek EGM, Bhardwaj R, Tompkins TA. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study. Eur. J. Clin. Nutr. 69(3), 385-391 (2015).
90. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med. Infect. Dis. 5(2), 97-105 (2007).
91. Roura E, Koopmans SJ, Lallès JP et al. Critical review evaluating the pig as model for human nutritional physiology. Nutr. Res. Rev. 29, 60-90 (2016).
92. Sams L, Paume J, Giallo J, Carrière F. Relevant pH and lipase for in vitro models of gastric digestion. Food Funct. 7(1), 30-45 (2016).
93. Heinritz SN, Mosenthin R, Weiss E. Use of pigs as a potential model for research into dietary modulation of the human microbiota. Nutr. Res. Rev. 26, 191-209 (2013).
94. Lundell K, Wikvall K. Species-specifc and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis. Curr. Drug. Metab. 9(4), 323-331 (2008).
95. Kararli TT Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug. Dispos. 16(5), 351-380 (1995).
96. Turner SM, Scott-Tucker A, Cooper LM, Henderson IR. Weapons of mass destruction: virulence factors of the global killer Enterotoxigenic Escherichia coli. FEMS Microbiol. Lett. 263, 10-20 (2006).
97. Geary SJ, Marchlewicz BA, Finkelstein RA. Comparison of heat-labile enterotoxins from porcine and human strains of Escherichia coli. Infect. Immun. 36(1), 215-220 (1982).
98. Zhang Q, Widmer G, Tzipori S. A pig model of the human gastrointestinal tract. Gut Microbes 4(3), 193-200 (2013).
99. Guerra A, Etienne-Mesmin L, Livrelli V, Denis S, Blanquet-Diot S, Alric M. Relevance and challenges in modeling human gastric and small intestinal digestion. Trends Biotechnol. 30(11), 591-600 (2012).
100. Payne AN, Chassard C, Banz Y, Lacroix C. The composition and metabolic activity of child gut microbiota demonstrate differential adaptation to varied nutrient loads in an in vitro model of colonic fermentation. FEMS Microbiol. Ecol. 80(3), 608-623 (2012).
101. Blanquet-Diot S, Denis S, Chalancon S, Chaira F, Cardot JM, Alric M. Use of artifcial digestive systems to investigate the biopharmaceutical factors infuencing the survival of probiotic yeast during gastrointestinal transit in humans. Pharm. Res. 29(6), 1444-1453 (2012).
102. TM module: a new tool to study the host-microbiota interaction in the human gastrointestinal tract in vitro. BMC Microbiol. 14 (133) (2014).